GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)

GlaxoSmithKline Pharmaceuticals Market Cap

GlaxoSmithKline Pharmaceuticals has a market cap or net worth of 416.18 billion as of November 15, 2024. Its market cap has increased by 71.79% in one year.

• Market Cap: 416.18B
• Enterprise Value: 395.22B
• Revenue: 35.60B
• Ranking: n/a
• PE Ratio: 61.66
• Stock Price: 2,456.70

Market Cap Chart

Since October 25, 2001, GlaxoSmithKline Pharmaceuticals's market cap has increased from 19.14B to 416.18B, an increase of 2,074.39%. That is a compound annual growth rate of 14.28%.

Market Cap History

Date	Market Cap	% Change
Nov 14, 2024	416.18B	29.48%
Dec 29, 2023	321.43B	43.86%
Dec 30, 2022	223.43B	-25.08%
Dec 31, 2021	298.24B	8.46%
Dec 31, 2020	274.98B	0.93%
Dec 31, 2019	272.46B	6.40%